BIOPHARMX CORPORATION APPOINTS STEPHEN MORLOCK TO
Post# of 223
Posted On: 03/30/2015 9:47:03 AM
BIOPHARMX CORPORATION APPOINTS STEPHEN MORLOCK
TO ITS BOARD OF DIRECTORS
Retail Industry Veteran to Support National Retail Roll-Out of Violet™ Iodine
MENLO PARK, Calif., March 30, 2015 — BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Stephen Morlock, a seasoned financial executive and retail industry veteran, to its board of directors. Mr. Morlock’s background will assist the company as it continues to expand its national roll-out of Violet iodine, the new, once-daily, non-prescription pill for relief of premenstrual breast discomfort, and he will serve as an independent board member on BioPharmX Corporation’s audit, compensation and nominating and corporate governance committees.
Morlock previously served as executive vice president and chief financial officer from 1994 to 2004 at Otis Spunkmeyer, a baked goods distribution company that has successfully pursued distribution of its products to small family-owned businesses all the way up to large worldwide organizations, including the U.S. Army. He served as controller there from 1992 to 1994. He also has experience garnered from these roles in various aspects of the retail industry, including going to market via various distribution channels, product merchandizing, customer relationship management, brand development, manufacturing, procurement, and inventory management.
“Stephen brings a unique blend of financial expertise and experience in the retail industry to BioPharmX,” said Jim Pekarsky, chief executive officer and co-founder of BioPharmX Corporation. “His expertise and experience will prove valuable as we continue retail distribution expansion for Violet iodine.” Prior to his roles at Otis Spunkmeyer, Morlock held various management positions in accounting, financial planning and internal auditing at Westinghouse Electric Supply Company from 1977 to 1991. He holds a B.S. degree in Accounting from San Diego State University.
TO ITS BOARD OF DIRECTORS
Retail Industry Veteran to Support National Retail Roll-Out of Violet™ Iodine
MENLO PARK, Calif., March 30, 2015 — BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Stephen Morlock, a seasoned financial executive and retail industry veteran, to its board of directors. Mr. Morlock’s background will assist the company as it continues to expand its national roll-out of Violet iodine, the new, once-daily, non-prescription pill for relief of premenstrual breast discomfort, and he will serve as an independent board member on BioPharmX Corporation’s audit, compensation and nominating and corporate governance committees.
Morlock previously served as executive vice president and chief financial officer from 1994 to 2004 at Otis Spunkmeyer, a baked goods distribution company that has successfully pursued distribution of its products to small family-owned businesses all the way up to large worldwide organizations, including the U.S. Army. He served as controller there from 1992 to 1994. He also has experience garnered from these roles in various aspects of the retail industry, including going to market via various distribution channels, product merchandizing, customer relationship management, brand development, manufacturing, procurement, and inventory management.
“Stephen brings a unique blend of financial expertise and experience in the retail industry to BioPharmX,” said Jim Pekarsky, chief executive officer and co-founder of BioPharmX Corporation. “His expertise and experience will prove valuable as we continue retail distribution expansion for Violet iodine.” Prior to his roles at Otis Spunkmeyer, Morlock held various management positions in accounting, financial planning and internal auditing at Westinghouse Electric Supply Company from 1977 to 1991. He holds a B.S. degree in Accounting from San Diego State University.
(0)
(0)